Enterprise Risk Management (ERM) Process
Our Enterprise Risk Management approach is geared towards building a risk intelligent culture that enables sound decision-making and helps the organization operate with greater resilience and efficiency. Our risk management process includes:
Risk Identification
Risk Assessment and Prioritization
Risk Treatment
Risk Monitoring and Review
Communication and Reporting
Our risk management process is aligned with globally recognized frameworks, including COSO ERM 2017 and ISO 31000:2018. It adopts both top-down and bottom-up approaches to ensure strategic oversight, early identification, and timely escalation of potential risks and issues.
Our framework spans across key risk categories such as financial, operational, regulatory, reputational, strategic, sustainability (ESG), talent, cybersecurity, and technology, enabling a structured and forward-looking risk mitigation process.
ERM Governance
Strides Pharma follows a structured three-level governance model to support the effective implementation of ERM objectives, ensuring accountability and consistency in risk identification, management, and escalation.
The Board, along with its Risk Management & Sustainability Committee (RM&SC), oversees risk governance by framing ERM policies, guiding management, and monitoring key risks and the effectiveness of risk management systems.
The ‘Risk Infrastructure & Management’ function is led by the Group Level Steering Committee (GLSC) and the Chief Risk Officer (CRO). The GLSC reviews key risks and promotes cross-functional mitigation strategies, while the CRO coordinates ERM activities via the Risk Office. Together with the RM&SC, they support the Board in maintaining independent risk oversight.
‘Risk Ownership’ lies with functional heads and risk owners, who identify emerging risks, monitor environments, and oversee mitigation efforts.
